<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02378792</url>
  </required_header>
  <id_info>
    <org_study_id>PINS-012</org_study_id>
    <nct_id>NCT02378792</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Vagus Nerve Stimulation for Treatment of Refractory Epilepsy</brief_title>
  <acronym>VNSRE</acronym>
  <official_title>The Clinical Research on TsingHua Vagus Nerve Stimualtor for Treatment of Refractory Epilepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Pins Medical Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Pins Medical Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the long-term clinical effectiveness and safety of the PINS vagus nerve stimulator
      to patients with refractory epilepsy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in seizure frequency from baseline to the seizure count evaluvation period 6 month</measure>
    <time_frame>4,8,12,16,20,24 months of stimulation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in seizure frequency from baseline to the seizure count evaluvation period</measure>
    <time_frame>4,8,12,16,20,24 months of stimulation</time_frame>
    <description>Changes in seizure frequency from baseline to 4,8,12,16,20,24 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Quality of Life in Epilepsy-31 (QOLIE-31) Score in Patients With Baseline &amp; at Least One Post-baseline QOLIE Assessment</measure>
    <time_frame>Mean change from baseline QOLIE-31 Overall Score at 12,24 months</time_frame>
    <description>QOLIE-31 contains 7 multi-item scales that tap the following health concepts:overall quality of life, emotional well-being, social functioning, energy/fatigue, worry about seizure,cognitive functioning,medication effects. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Number of Anti-epileptic Drugs Prescribed</measure>
    <time_frame>At12,24 months</time_frame>
    <description>Changes in Anti-Epileptic Drugs (AEDs) in patients with less then a 50% reduction in seizures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Basline in the Engel and McHugh description</measure>
    <time_frame>At 12,24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Basline in 24 hour ECG description</measure>
    <time_frame>At 12,24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Refractory Epilepsy</condition>
  <arm_group>
    <arm_group_label>Vagus Verve Stimulation is on</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Vagus Verve Stimulation is off</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vagus Nerve Stimulation</intervention_name>
    <description>Vagus Nerve Stimulator</description>
    <arm_group_label>Vagus Verve Stimulation is on</arm_group_label>
    <arm_group_label>Placebo Vagus Verve Stimulation is off</arm_group_label>
    <other_name>PINS Stimulator System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 6-60.

          2. Having tried at least two appropriate anti-epileptic drugs (AEDs) tested to tolerance
             or to blood levels at upper end of the target range of which at least 2 have been
             tolerated at normal dose.

          3. At least 1 seizure per month.

          4. In good health except epilepsy.

          5. With normal MMSE score

          6. Patients or his(her) familyscould understand this method and sign the informed consent
             7）Patients with good compliance and could complete postoperative follow-up.

        Exclusion Criteria:

          1. Results of MRI remind epilepsy caused by intracranial space-occupying lesions.

          2. The vagus nerve lesion and damage

          3. Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma，mental
             disease，pepticulcer，diabetes Type 1，bad health etc, and other surgical
             contraindication

          4. Alcohol addiction, smoking, and sleep-related breathing disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jia Fumin, PhD</last_name>
    <phone>+86 010-59361265</phone>
    <email>pins_medical@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li Luming, PhD</last_name>
    <phone>+86 010-60736388</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianguo Zhang, MD</last_name>
      <phone>010-67096611</phone>
      <email>Limuxin2011@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first hospital of jilin university</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kan Xu, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jiqing Qiu</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The general of shenyang military</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guobiao Liang, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Guanqian Yuan</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Qilu hospital of shandong university</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shujun Xu, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Wenhua Zhang</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The second affiliated hospital zhejiang university school of medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weiming FU, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Junming Zhu</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2015</study_first_posted>
  <last_update_submitted>October 11, 2016</last_update_submitted>
  <last_update_submitted_qc>October 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PINS VNS Refractory Epilepsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

